Annual Retained Earnings
-$194.97 M
-$6.68 M-3.55%
December 31, 2023
Summary
- As of February 7, 2025, TRDA annual retained earnings is -$194.97 million, with the most recent change of -$6.68 million (-3.55%) on December 31, 2023.
- During the last 3 years, TRDA annual retained earnings has fallen by -$152.46 million (-358.63%).
- TRDA annual retained earnings is now -1119.48% below its all-time high of -$15.99 million, reached on December 31, 2019.
Performance
TRDA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$130.47 M
-$14.03 M-12.05%
September 30, 2024
Summary
- As of February 7, 2025, TRDA quarterly retained earnings is -$130.47 million, with the most recent change of -$14.03 million (-12.05%) on September 30, 2024.
- Over the past year, TRDA quarterly retained earnings has increased by +$54.95 million (+29.64%).
- TRDA quarterly retained earnings is now -206.92% below its all-time high of -$42.51 million, reached on December 31, 2020.
Performance
TRDA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TRDA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | +29.6% |
| 3 y3 years | -358.6% | +30.7% |
| 5 y5 years | -1119.5% | +30.7% |
TRDA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -108.2% | at low | -39.3% | +40.9% |
| 5 y | 5-year | -1119.5% | at low | -206.9% | +40.9% |
| alltime | all time | -1119.5% | at low | -206.9% | +40.9% |
Entrada Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$130.47 M(+12.1%) |
| Jun 2024 | - | -$116.44 M(-32.1%) |
| Mar 2024 | - | -$171.47 M(-12.1%) |
| Dec 2023 | -$194.97 M(+3.6%) | -$194.97 M(+5.1%) |
| Sep 2023 | - | -$185.43 M(-16.1%) |
| Jun 2023 | - | -$220.89 M(+13.3%) |
| Mar 2023 | - | -$194.96 M(+3.5%) |
| Dec 2022 | -$188.28 M | -$188.28 M(+15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$163.66 M(+18.1%) |
| Jun 2022 | - | -$138.52 M(+20.1%) |
| Mar 2022 | - | -$115.34 M(+23.1%) |
| Dec 2021 | -$93.67 M(+120.3%) | -$93.67 M(+24.5%) |
| Sep 2021 | - | -$75.22 M(+23.7%) |
| Jun 2021 | - | -$60.79 M(+43.0%) |
| Dec 2020 | -$42.51 M(+165.9%) | -$42.51 M |
| Dec 2019 | -$15.99 M | - |
FAQ
- What is Entrada Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Entrada Therapeutics?
- What is Entrada Therapeutics annual retained earnings year-on-year change?
- What is Entrada Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly retained earnings year-on-year change?
What is Entrada Therapeutics annual retained earnings?
The current annual retained earnings of TRDA is -$194.97 M
What is the all time high annual retained earnings for Entrada Therapeutics?
Entrada Therapeutics all-time high annual retained earnings is -$15.99 M
What is Entrada Therapeutics annual retained earnings year-on-year change?
Over the past year, TRDA annual retained earnings has changed by -$6.68 M (-3.55%)
What is Entrada Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TRDA is -$130.47 M
What is the all time high quarterly retained earnings for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly retained earnings is -$42.51 M
What is Entrada Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TRDA quarterly retained earnings has changed by +$54.95 M (+29.64%)